NEWS

We inform you about the current business development of HAEMATO AG and about our investor relations activities.

Ad-hoc disclosure under Art.17 MAR

Ad-hoc disclosure under Art.17 MAR

HAEMATO AG: Ad-hoc disclosure under Article 17 MAR HAEMATO AG: MPH Health Care AG brings its shares in HAEMATO AG to M1 Kliniken AG as part of a non-cash capital increase. Today MPH Health Care AG and M1 Kliniken AG informed us that MPH Health Care AG transfers all of...

read more
appropriation of profits

appropriation of profits

The Supervisory Board of HAEMATO AG (ISIN: DE0006190705) approved today’s proposal for the appropriation of profits by the Management Board in today’s balance sheet meeting. Accordingly, the management of the Annual General Meeting on July 8, 2020 will propose that the retained earnings for the 2019 financial year be carried forward to new account.

read more
Ad-Hoc-News from 07.07.2017

Ad-Hoc-News from 07.07.2017

In today's meeting, the Supervisory Board of HAEMATO AG ("HAEMATO" or the "Company") accepted the wish of Dr. Christian Pahl to not extend his contract as Management Board Member beyond the current term ending 31 July 2017. The Supervisory Board regrets...

read more
AD-HOC-NEWS from 05.05.2017

AD-HOC-NEWS from 05.05.2017

HAEMATO AG: Capital increase from authorized capital under exclusion of existing shareholders' subscription rights resolved and successfully implemented. The Management Board of HAEMATO AG, Schönefeld, (ISIN: DE0006190705) decided today with the approval...

read more

HAEMATO AG

HAEMATO AG
Lilienthalstraße 5c
12529 Schönefeld
Germany

Phone: +49-30 897 30 86 70
Telefax: +49-30 897 30 86 79
E-Mail: info@haemato.ag